Preprint · CC-BY
via OpenAlex
Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer’s disease
Josué Ballesteros‐Álvarez, Wynnie Nguyen, Renuka Sivapatham, Anand Rane, Julie Kay Andersen
Research Square · 2022 · ▲ 4 citations
Abstract
Abstract Background In recent years, a burgeoning body of evidence has pointed to age-related dysfunction in neuronal autophagy(definition) as playing a prominent role in neuropathology associated with Alzheimer’s disease (AD). In the present study, we investigated the effects of urolithin A (UA), a metabolite generated from ellagic acid via its metabolism by gut bacteria, as an autophagy activator with potential neuroprotective activity. Methods WT and 3xTg-AD mice were administered long-term intermittent dietary supplementation with UA. Following evaluation of spatial learning and memory, associative learning and exploratory behavior, we employed fluorescence-based immunodetection of human Aβ42 + Aβ40 to determine Aβ plaque deposition and quantified Aβ42 in hippocampal and cortical homogenates via sandwich ELISA in 14-months old mice. Using neuronal cell types, we analyzed the effects of UA on the expression of autophagy genes and proteins and on lysosomal acidification. We treated mouse hippocampal cells with Aβ oligomers while inducing autophagy with UA and analyzed Aβ clearance. Results UA was found to prevent behavioral deficits in this model. It also decreased the Aβ plaque burden in areas of the hippocampus where these protein deposits are prominent in the model. Interestingly, correlation analyses demonstrate that Aβ plaque burden positively correlates with enhanced spatial memory in 3xTg mice on a control diet but not in those supplemented with UA. In contrast, Aβ42 abundance in cortical and hippocampal homogenates negatively correlate with spatial memory in UA-fed mice. UA was also found to extend lifespan in normal aging mice. Mechanistically, we demonstrate that UA is able to induce autophagy and to increase Aβ clearance in neuronal cell lines. Conclusions In summary, our data suggest that plaque formation may be a protective mechanism against neurodegeneration and cognitive decline and that targeting the generation of proteotoxic Aβ species might be a more successful approach in halting disease progression than targeting plaque formation. UA, likely via its actions as a autophagy inducer, is capable of removing Aβ from neurons and its dietary administration prevents the onset of cognitive deficits associated with pathological Aβ deposition the 3xTg AD mouse model as well as extending lifespan in normal aging mice.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.21203/rs.3.rs-2046848/v1
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Ballesteros‐Álvarez, J., Nguyen, W., Sivapatham, R., Rane, A., & Andersen, J.K. (2022). Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer’s disease. <em>Research Square</em>. https://doi.org/10.21203/rs.3.rs-2046848/v1
Vancouver
Ballesteros‐Álvarez J, Nguyen W, Sivapatham R, Rane A, Andersen JK. Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer’s disease. Research Square. 2022. doi:10.21203/rs.3.rs-2046848/v1.
BibTeX
@unpublished{josu2022Urolit,
title = {Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer’s disease},
author = {Josué Ballesteros‐Álvarez and Wynnie Nguyen and Renuka Sivapatham and Anand Rane and Julie Kay Andersen},
journal = {Research Square},
year = {2022},
doi = {10.21203/rs.3.rs-2046848/v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Research Square 2022
Preprint · CC-BY
Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer’s disease
GeroScience 2022
Open access · CC-BY
Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer’s disease
Journal of Bone and Mineral Research 2016
Preprint · OA
Identification of Senescent Cells in the Bone Microenvironment
Annals of Translational Medicine 2021
Open access · CC-BY
Young plasma attenuates cognitive impairment and the cortical hemorrhage area in cerebral amyloid angiopathy model mice
Molecular biomedicine 2026
Open access · OA
Targeted neuronal reprogramming rescues memory and neural synchrony in Alzheimer's disease.
Frontiers in aging neuroscience 2025
Open access · OA